
Conversion of the LXR-agonist TO-901317—From inverse to normal modulation of γ-secretase by addition of a carboxylic acid and a lipophilic anchor
Keywords: Alzheimer’s disease; γ-Secretase modulator; LXR agonist; γ-Secretase inhibitor; Aspartic protease; Membrane protease